首页> 外文期刊>Therapeutic Drug Monitoring >Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies
【24h】

Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies

机译:LC-MS / MS法测定他克莫司在大鼠肾脏和肝脏组织中的方法的验证及其在人肾脏活检中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND:: Tacrolimus (TAC) has a narrow therapeutic index and high interindividual and intraindividual pharmacokinetic variability, necessitating therapeutic drug monitoring to individualize dosage. Recent evidence suggests that intragraft TAC concentrations may better predict transplant outcomes. This study aimed to develop a method for the quantification of TAC in small biopsy-sized samples of rat kidney and liver tissue, which could be applied to clinical biopsy samples from kidney transplant recipients. METHODS:: Kidneys and livers were harvested from Mrp2-deficient TR- Wistar rats administered TAC (4 mg·kg·d for 14 days, n = 8) or vehicle (n = 10). Tissue samples (0.20-1.00 mg of dry weight) were solubilized enzymatically and underwent liquid-liquid extraction before analysis by liquid chromatography tandem mass spectrometry method. TAC-free tissue was used in the calibrator and quality control samples. Analyte detection was accomplished using positive electrospray ionization (TAC: m/z 821.5 → 768.6; internal standard ascomycin m/z 809.3 → 756.4). RESULTS:: Calibration curves (0.04-2.6 μg/L) were linear (R > 0.99, n = 10), with interday and intraday calibrator coefficients of variation and bias <17% at the lower limit of quantification and <15% at all other concentrations (n = 6-10). Extraction efficiencies for TAC and ascomycin were approximately 70%, and matrix effects were minimal. Rat kidney TAC concentrations were higher (range 109-190 pg/mg tissue) than those in the liver (range 22-53 pg/mg of tissue), with median tissue/blood concentrations ratios of 72.0 and 17.6, respectively. In 2 transplant patients, kidney TAC concentrations ranged from 119 to 285 pg/mg of tissue and were approximately 20 times higher than whole blood trough TAC concentrations. CONCLUSIONS:: The method displayed precision and accuracy suitable for application to TAC measurement in human kidney biopsy tissue.
机译:背景:他克莫司(TAC)具有较窄的治疗指数和较高的个体间和个体内药代动力学变异性,因此有必要对治疗药物进行监测以个性化剂量。最新证据表明,移植物中TAC的浓度可能更好地预测移植结果。这项研究旨在开发一种定量分析大鼠肾脏和肝脏组织的小样本活检样品中TAC的方法,该方法可用于肾脏移植受者的临床活检样品。方法:从缺乏Mrp2的TR-Wistar大鼠中,以TAC(4 mg·kg·d,连续14天,n = 8)或赋形剂(n = 10)收集肾脏和肝脏。将组织样品(0.20-1.00 mg干重)酶解并进行液-液萃取,然后通过液相色谱串联质谱法进行分析。不含TAC的组织用于校准品和质量控制样品中。使用正电喷雾电离(TAC:m / z 821.5→768.6;内标子囊霉素m / z 809.3→756.4)完成分析物检测。结果::校准曲线(0.04-2.6μg/ L)是线性的(R> 0.99,n = 10),日间和日内校准物的变异系数和偏差在定量下限时<17%,在所有情况下<15%其他浓度(n = 6-10)。 TAC和子囊霉素的提取效率约为70%,基质效应最小。大鼠肾脏TAC浓度(范围为109-190 pg / mg组织)高于肝脏(范围为22-53 pg / mg组织),组织/血液中位数浓度比分别为72.0和17.6。在2名移植患者中,肾脏TAC浓度范围为119至285 pg / mg组织,比全血谷TAC浓度高约20倍。结论:该方法显示出适用于人肾活检组织中TAC测量的精确度和准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号